August 21, 2026
Most care home developers know roughly what their project will cost. Fewer have a clear picture of how to fund it.
Development finance for care homes is more complex than standard commercial property lending. Lenders are not just underwriting the bricks — they are underwriting the operating business that will run inside them, the CQC registration process, and a fill-up period where income does not yet cover costs. Get the finance structure wrong and a viable project becomes unviable, not because the numbers do not work but because the wrong debt is in the wrong place.
This guide covers the main funding routes, how they stack together, what lenders actually check on a care home project, and where the common mistakes are made.
|
55–65% typical senior debt LTV against GDV on a care home development |
30–36 months typical full facility term — construction plus stabilisation period |
1.25× minimum DSCR most lenders require at stabilised occupancy before they will refinance |
Care home development finance is usually built in layers. Each layer has a different cost, a different risk profile, and a different position in the repayment queue if something goes wrong.
|
Layer |
Typical LTV range |
Cost (2026) |
Who provides it |
|
Senior debt |
Up to 55–65% of GDV |
7–9% per annum |
Development finance lenders, banks, specialist healthcare lenders |
|
Mezzanine finance |
65–80% of GDV |
12–18% per annum |
Mezzanine funds, specialist lenders |
|
Preferred equity |
Similar to mezz |
14–20% per annum |
Private equity, family offices |
|
Developer equity |
Remaining gap |
Your own return on risk |
Developer / operator |
|
Forward funding |
100% of costs (no LTV) |
Fixed development margin |
Institutional investors, REITs, healthcare funds |
Most first-time care home developers underestimate how much equity they need. Senior debt at 60% LTV against a £19m GDV gives you £11.4m. Your project costs £13m all-in. That £1.6m gap needs to come from somewhere — mezzanine, a JV partner, or your own capital.
Senior development finance is the main construction loan. It funds land acquisition (if not already owned) and the build programme, drawing down in tranches as work progresses.
For care homes, the facility typically covers:
• Land purchase or refinance of existing site
• Construction costs, drawn in tranches against architect or monitoring surveyor certificates
• Professional fees and planning costs
• Interest rolled up during construction (usually — some lenders allow current payment)
• A contingency facility for cost overruns
Care home development lenders underwrite differently to standard commercial lenders. The key metrics:
|
Metric |
What lenders check |
Typical threshold |
|
LTV against GDV |
Loan as % of the completed, stabilised value |
55–65% maximum |
|
Loan to Cost (LTC) |
Loan as % of total development cost |
70–80% maximum |
|
DSCR at stabilisation |
EBITDARM coverage of debt service once the home is trading |
1.25×1.35× minimum |
|
Operator covenant |
Financial strength and CQC track record of the operator |
Rated operators preferred |
|
Planning status |
Full permission in place, not outline |
Full PP required to draw |
|
Exit route |
How the loan gets repaid — sale, refinance, or operating cashflow |
Clear exit at term |
New care homes open at 20–30% occupancy and take 12–18 months to reach stable occupancy. We covered this in detail in our guide to fees and investor returns. During that period, the home is not generating enough income to service a long-term debt facility.
Most development lenders build this into the facility term. A standard care home development loan runs 18–24 months for construction, plus a 12–18 month stabilisation period before the exit is triggered. The total facility term is typically 30–36 months.
Some lenders will not extend into the stabilisation period and require refinance onto a term loan at practical completion. That refinance is only available once the home is trading at or near the DSCR threshold. If fill-up is slow, you are carrying a maturing construction loan against a home that is not yet generating enough income to refinance. That is the single biggest financial risk on a new care home development.
|
Model the fill-up period explicitly. Assume 12–18 months to reach 85% occupancy. Confirm your senior lender’s position on the stabilisation period before you draw the first tranche, not after practical completion. |
Senior development finance for care homes in 2026 is typically priced at 7–9% per annum, depending on the lender, LTV, and strength of the project. Additional costs to budget for:
• Arrangement fee: 1–2% of the facility, paid on drawdown
• Monitoring surveyor: 0.5–1% of the loan; lender-appointed, developer-paid. Their sign-off is required on every tranche draw
• Exit fee: 0.5–1% of the facility on repayment, charged by some lenders
• Valuation: £5,000–15,000 depending on scheme size; lender-appointed
• Legal costs: Both sides' legal costs are typically developer-paid on development finance
On a £12m facility, total finance costs including rolled interest over a 28-month programme at 8% run to roughly £2.2–2.5m. That needs to be in your development appraisal from day one.
Mezzanine finance sits between senior debt and the developer’s own equity. It fills the gap when senior debt does not cover enough of the development cost and the developer does not have — or does not want to deploy — enough equity to cover the difference.
On a £19m GDV scheme with £13m all-in costs:
|
Layer |
Amount |
Source |
|
Senior debt (60% of GDV) |
£11.4m |
Development lender |
|
Mezzanine (to 75% of GDV) |
£2.85m |
Mezzanine fund |
|
Developer equity |
£2.75m (21% of cost) |
Developer |
|
Total |
£17m |
— |
|
Gap to full cost (£13m) |
£4m — drawn from facility tranches as costs are incurred |
— |
The mezzanine lender sits behind the senior lender in the security stack. If the project fails, the senior lender gets paid first. Because mezzanine lenders carry more risk, they charge significantly more — 12–18% per annum is typical in 2026.
Mezzanine makes sense when the project return justifies the cost of the additional debt. If your projected development profit is 18–22% on cost, paying 15% per annum for mezzanine over an 18-month construction period costs roughly 3–4% of the loan value — expensive but viable. If your projected margin is 10%, mezzanine consumes most of it.
|
Mezzanine is a tool for bridging a specific equity gap, not a substitute for adequate equity. If the project only works with mezzanine at 75% LTV, ask whether the project is adequately capitalised or whether the development appraisal needs revisiting. |
Forward funding is a different structure entirely. Instead of building and then selling or refinancing, the developer agrees a deal with an institutional investor before construction starts. The investor funds the development and takes ownership of the completed asset. The developer delivers the build and earns a fixed development margin.
It is the most common structure for large care home schemes with institutional operators, and it removes two of the biggest risks in care home development: the exit risk (finding a buyer at the right yield once the home is built) and the fill-up risk (carrying a debt facility while the home ramps up to occupancy).
• The developer and investor agree a forward funding deal before planning is granted or shortly after. The key terms: development cost cap, development margin (typically 15–20% on cost), and the passing rent the investor will receive once the home is operational.
• The investor funds each construction tranche as work is certified by the monitoring surveyor. The developer does not need to arrange separate senior debt — the investor is effectively the funder.
• At practical completion, the developer hands over the building. The operator (who is usually pre-agreed as part of the deal) moves in, and the investor begins receiving rent.
• The developer takes their margin and exits. They are not exposed to fill-up, CQC registration delays, or long-term operating performance.
Healthcare REITs, specialist healthcare property funds, and institutional investors with long-term income mandates. In the UK care home sector, active forward funders include dedicated healthcare property companies and long-lease income funds. They target initial yields of 5.5–6.5% on prime schemes in the South East.
To attract forward funding, you typically need:
• Full planning permission in place or near-certain
• A pre-agreed operator with a strong CQC track record
• A scheme of 60 beds or more — smaller schemes are too small to be efficient for institutional investors to underwrite
• A South East or similarly supply-constrained location
• A purpose-built design, not a conversion
Forward funding and forward sale are often confused. In a forward sale, the developer builds using their own debt and sells the completed asset to an investor at an agreed price. The developer carries the construction risk and the exit is fixed but the income risk during fill-up sits with the buyer.
Forward funding removes the developer’s need to arrange construction finance. Forward sale removes the developer’s exit risk but still requires them to fund the build. Both structures require the investor to be found before construction starts, which is why operator quality and planning status are the first things institutional buyers check.
Not all care home funding is private. There are publicly-backed routes worth understanding, particularly for schemes that serve NHS Integrated Care Board priorities or local authority market sustainability objectives.
• Section 256 agreements: NHS bodies can fund capital improvements in care homes under Section 256 of the NHS Act, typically tied to the home providing NHS-funded beds or step-down capacity. Relatively rare but worth exploring in areas where the ICB has a stated capacity gap.
• Local authority capital grants: Some councils offer capital grants for care home development in areas with acute supply shortfalls, particularly for dementia and nursing beds. Usually tied to a proportion of LA-funded placements at agreed rates.
• Homes England / Integrated Care Fund: Grant funding for certain types of specialist and supported housing. Care homes sit at the edge of this funding territory — eligibility depends on the care model and the ICB’s local priorities.
• Social impact bonds and blended finance: Emerging in some areas for specialist learning disability and dementia schemes where local authority commissioners are willing to underwrite demand in exchange for agreed pricing.
Public funding routes take longer and require the developer to engage with NHS and council procurement processes that have their own timelines. They are not a substitute for a fundable development appraisal — they are additional capital that can make a marginal scheme viable or improve the return on an already viable one.
This is the practical checklist. Assemble this before you approach lenders, not in response to their information requests.
|
Document / item |
Why lenders need it |
|
Full planning permission |
Development finance does not draw without it. Outline permission is not enough. |
|
Development appraisal |
Full cost stack, GDV calculation, profit on cost, sensitivity analysis on fee rate and occupancy. |
|
Operator agreement or heads of terms |
Lenders want to know who is running the home before they fund it. An experienced operator with a clean CQC record materially reduces the perceived risk. |
|
Architect’s certificate and cost plan |
QS-prepared cost plan, not a builder’s estimate. Lenders appoint their own monitoring surveyor to check it. |
|
Latent defects insurance (LDI) policy |
Must be with a provider on the lender’s approved list. Arrange before groundworks. |
|
Collateral warranties |
From contractor and key professionals. Required at drawdown or as a condition of first tranche. |
|
CQC pre-registration evidence |
Evidence that the operator has engaged with CQC pre-registration. Lenders want to see this is in progress. |
|
Personal guarantees |
Most development lenders require PGs from directors on smaller schemes. Larger, well-capitalised developers may negotiate away from this. |
To make the funding structure concrete, here is a worked capital stack for a 70-bed mid-range nursing home in the South East.
|
Item |
Figure |
|
Total development cost (land, build, fees, FF&E, contingency) |
£19.0m |
|
GDV (stabilised, at 7% yield on £1.3m EBITDARM) |
£18.6m |
|
Senior debt (60% of GDV) |
£11.2m |
|
Mezzanine (to 75% of GDV) |
£2.6m |
|
Developer equity required |
£5.2m (27% of total cost) |
|
Rolled interest on senior debt (28 months at 8%) |
£2.1m |
|
Arrangement and exit fees (2% in, 1% out) |
£450k |
|
Mezzanine interest (15% over 18 months) |
£585k |
|
Total finance cost |
£3.1m |
|
Residual development profit (GDV minus cost minus finance) |
£≈1.5m — approx 8% on cost |
An 8% profit on cost is thin for a care home development in the South East, where site finding is hard and planning is uncertain. Forward funding at a fixed 15–18% development margin would be more attractive on this scheme if an institutional buyer can be found pre-planning. The trade-off is that the forward funder takes the long-term asset — the developer takes the margin and moves on.
These numbers connect directly to the GDV model we set out in our guide to build cost versus fee income. The finance structure only works if the underlying EBITDARM projection is realistic. A £200/week error in the fee assumption reduces GDV by £2–3m and can turn a viable project into an unviable one before a single tranche is drawn.
How much equity do I need to develop a care home?
It depends on the funding structure. With senior debt at 60% LTV and mezzanine to 75%, you need 25–30% of total development cost in equity. On a £13m project, that is £3.25–3.9m. With forward funding, the equity requirement is much lower — you are contributing your land, planning, and development expertise rather than cash. Most lenders also require enough working capital to cover cost overruns and the fill-up period without drawing on the facility.
Can I get development finance without a planning permission?
Senior development finance for care homes requires full planning permission before the first tranche draws. Some lenders will offer a bridge loan to fund the planning process and land acquisition, which then converts to development finance on grant of permission. The bridge rate is higher and the exit to development finance is conditional on permission being granted, so the risk sits with the developer.
What is a monitoring surveyor and who pays for them?
A monitoring surveyor (also called a project monitor) is appointed by the lender to independently verify that construction is progressing as certified before each tranche is released. They check quality, programme, and cost against the agreed cost plan. The developer pays their fee, which runs at 0.5–1% of the loan. Their sign-off is a condition of every tranche draw, so a good working relationship with the monitoring surveyor matters.
What happens if the home fills up slower than expected?
This is the most common source of financial stress on a new care home. If the senior lender’s facility matures before the home reaches the DSCR required for refinancing, the developer needs either an extension of the facility (at cost) or additional equity to bridge the gap. Model a slow fill-up scenario — 18–24 months to 85% occupancy rather than 12 — before you agree a facility term.
What is the difference between forward funding and forward sale?
In forward funding, the institutional investor funds the build from the start — the developer does not need to arrange separate construction finance. In a forward sale, the developer builds using their own debt and sells to the investor at a pre-agreed price on completion. Forward funding removes the need for construction finance but the investor owns the asset. Forward sale requires construction finance but the developer has more control until practical completion.
Do care home development lenders require personal guarantees?
Usually yes on smaller schemes and for developers without a significant track record. The guarantee is typically limited to cost overruns rather than the full facility. Developers with a strong balance sheet and a track record of delivering care home schemes successfully can sometimes negotiate away from personal guarantees, but it is the exception rather than the rule.
The finance structure for a care home project needs to be worked out alongside the development appraisal, not after it. At Care Home Builders we work with developers from feasibility through to handover, and we understand what lenders need to see before they will fund a healthcare scheme.
We build care homes across London and the South East. If you are at early stage on a project and want to understand how the numbers fit together, talk to us.